- For Narcoleptics, a ‘New Chapter’ Newser
- FDA Approves First Drug to Treat a Cause of Narcolepsy Time Magazine
- This Newly Approved Narcolepsy Drug Is the First to Target the Sleep Disorder’s Root Cause Rather Than Its Symptoms Smithsonian Magazine
- The brain may be about to have its Ozempic moment AFR
- Takeda Pharmaceutical (TSE:4502) Wins FDA Approval For ORZEYFUL, Is The Stock Still Cheap? simplywall.st